These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38889277)

  • 1. OLB-AC: toward optimizing ligand bioactivities through deep graph learning and activity cliffs.
    Yin Y; Hu H; Yang J; Ye C; Goh WWB; Kong AW; Wu J
    Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38889277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employing Molecular Conformations for Ligand-Based Virtual Screening with Equivariant Graph Neural Network and Deep Multiple Instance Learning.
    Gu Y; Li J; Kang H; Zhang B; Zheng S
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest.
    Wu J; Zhang Q; Wu W; Pang T; Hu H; Chan WKB; Ke X; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2271-2282. PubMed ID: 29432522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFSE: towards improving model generalization of deep graph learning of ligand bioactivities targeting GPCR proteins.
    Yin Y; Hu H; Yang Z; Jiang F; Huang Y; Wu J
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35348582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise modelling and interpretation of bioactivities of ligands targeting G protein-coupled receptors.
    Wu J; Liu B; Chan WKB; Wu W; Pang T; Hu H; Yan S; Ke X; Zhang Y
    Bioinformatics; 2019 Jul; 35(14):i324-i332. PubMed ID: 31510691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer learning with molecular graph convolutional networks for accurate modeling and representation of bioactivities of ligands targeting GPCRs without sufficient data.
    Wu J; Lan C; Mei Z; Chen X; Zhu Y; Hu H; Diao Y
    Comput Biol Chem; 2022 Jun; 98():107664. PubMed ID: 35325760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GraphscoreDTA: optimized graph neural network for protein-ligand binding affinity prediction.
    Wang K; Zhou R; Tang J; Li M
    Bioinformatics; 2023 Jun; 39(6):. PubMed ID: 37225408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RealVS: Toward Enhancing the Precision of Top Hits in Ligand-Based Virtual Screening of Drug Leads from Large Compound Databases.
    Yin Y; Hu H; Yang Z; Xu H; Wu J
    J Chem Inf Model; 2021 Oct; 61(10):4924-4939. PubMed ID: 34619030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Domain-Specific Fingerprints Generated Through Neural Networks to Enhance Ligand-Based Virtual Screening.
    Menke J; Koch O
    J Chem Inf Model; 2021 Feb; 61(2):664-675. PubMed ID: 33497572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.
    Ruiz Puentes P; Rueda-Gensini L; Valderrama N; Hernández I; González C; Daza L; Muñoz-Camargo C; Cruz JC; Arbeláez P
    Sci Rep; 2022 May; 12(1):8434. PubMed ID: 35589824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous G Protein-Coupled Receptors Boost the Modeling and Interpretation of Bioactivities of Ligand Molecules.
    Wu J; Sun Y; Chan WKB; Zhu Y; Zhu W; Huang W; Hu H; Yan S; Pang T; Ke X; Li F
    J Chem Inf Model; 2020 Mar; 60(3):1865-1875. PubMed ID: 32040913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand binding affinity prediction with fusion of graph neural networks and 3D structure-based complex graph.
    Dong L; Shi S; Qu X; Luo D; Wang B
    Phys Chem Chem Phys; 2023 Sep; 25(35):24110-24120. PubMed ID: 37655493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network-principled deep generative models for designing drug combinations as graph sets.
    Karimi M; Hasanzadeh A; Shen Y
    Bioinformatics; 2020 Jul; 36(Suppl_1):i445-i454. PubMed ID: 32657357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QPoweredCompound2DeNovoDrugPropMax - a novel programmatic tool incorporating deep learning and
    Geoffrey A S B; Madaj R; Valluri PP
    J Biomol Struct Dyn; 2023 Mar; 41(5):1790-1797. PubMed ID: 35007471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMMS-GCL: cross-modality metabolic stability prediction with graph contrastive learning.
    Du BX; Long Y; Li X; Wu M; Shi JY
    Bioinformatics; 2023 Aug; 39(8):. PubMed ID: 37572298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery.
    Rifaioglu AS; Cetin Atalay R; Cansen Kahraman D; Doğan T; Martin M; Atalay V
    Bioinformatics; 2021 May; 37(5):693-704. PubMed ID: 33067636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring QSAR models for activity-cliff prediction.
    Dablander M; Hanser T; Lambiotte R; Morris GM
    J Cheminform; 2023 Apr; 15(1):47. PubMed ID: 37069675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UniDL4BioPep: a universal deep learning architecture for binary classification in peptide bioactivity.
    Du Z; Ding X; Xu Y; Li Y
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37020337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.